Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study

@article{Gyngysi2009CombinedDA,
  title={Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study},
  author={M. Gy{\"o}ngy{\"o}si and I. Lang and M. Dettke and G. Beran and S. Graf and H. Sochor and N. Nyolczas and S. Charwat and R. Hemetsberger and G. Christ and I. Edes and L. Balogh and K. Krause and K. Jaquet and K. Kuck and I. Benedek and T. Hintea and R. Kiss and I. Pr{\'e}da and V. Kotevski and H. Pejkov and Sholeh Zamini and A. Khorsand and G. Sodeck and A. Kaider and G. Maurer and D. Glogar},
  journal={Nature Clinical Practice Cardiovascular Medicine},
  year={2009},
  volume={6},
  pages={70-81}
}
  • M. Gyöngyösi, I. Lang, +24 authors D. Glogar
  • Published 2009
  • Medicine
  • Nature Clinical Practice Cardiovascular Medicine
  • Background Combined intracoronary and intramyocardial administration might improve outcomes for bone-marrow-derived stem cell therapy for acute myocardial infarction (AMI). We compared the safety and feasibility of early and late delivery of stem cells with combined therapy approaches.Methods Patients with left ventricular ejection fraction less than 45% after AMI were randomly assigned stem cell delivery via intramyocardial injection and intracoronary infusion 3–6 weeks or 3–4 months after AMI… CONTINUE READING
    127 Citations
    Timing for intracoronary administration of bone marrow mononuclear cells after acute ST-elevation myocardial infarction: a pilot study
    • 17
    Stem Cells Therapy for Acute Myocardial Infarction: A Literature Review
    Randomized transcoronary delivery of CD34+ cells with perfusion versus stop-flow method in patients with recent myocardial infarction: Early cardiac retention of 99mTc-labeled cells activity
    • P. Musialek, L. Tekieli, +11 authors W. Tracz
    • Medicine
    • Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
    • 2011
    • 40
    • PDF
    CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent.
    • 139
    • Highly Influenced
    • PDF
    Bone Marrow‐Derived Cell Transplantation Therapy for Myocardial Infarction: Lessons Learned and Future Questions
    • W. Dai, R. Kloner
    • Medicine
    • American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
    • 2011
    • 20
    Bone marrow mononuclear stem cells: potential in the treatment of myocardial infarction
    • 8
    • PDF

    References

    SHOWING 1-10 OF 60 REFERENCES
    Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.
    • 1,379
    • PDF
    Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.
    • 1,311
    • PDF